Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
1(50.0%)
N/A
1(50.0%)
2Total
Phase 3(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06164444Not ApplicableRecruiting

Disposable Versus Reusable DrApes and Gowns for Green OperatiNg Theatres

Role: collaborator

NCT06208592Completed

Comparative Study of Anaconda System Use Versus Conventional Sedation in COVID-19 Patients.

Role: lead

NCT03835286Phase 3Withdrawn

Vitamin C to Reduce Vasopressor Dose in Septic Shock

Role: lead

All 3 trials loaded